Emicizumab for the treatment of haemophilia A: a narrative review

One of the most serious complications of the treatment of severe haemophilia A is the development of alloantibodies against exogenous factor VIII (FVIII). Inhibitors render factor replacement therapy ineffective, exposing patients to a remarkably high risk of morbidity and mortality. Besides the wel...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Blood Transfus
Autores principales: Franchini, Massimo, Marano, Giuseppe, Pati, Ilaria, Candura, Fabio, Profili, Samantha, Veropalumbo, Eva, Masiello, Francesca, Catalano, Liviana, Piccinini, Vanessa, Vaglio, Stefania, Pupella, Simonetta, Liumbruno, Giancarlo M.
Formato: Artigo
Lenguaje:Inglês
Publicado: Edizioni SIMTI - SIMTI Servizi Srl 2019
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6596376/
https://ncbi.nlm.nih.gov/pubmed/31246563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2450/2019.0026-19
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares